Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-034483)

Filing Details

Accession Number:: 0000899243-20-034483
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-18 16:30:22
Reporting Period:: 2020-12-16

Accepted Time:: 2020-12-18 16:30:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1733143	Ralf Kuriyel	C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453	Senior Vp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-12-16	435	$186.18	25,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.